- Nelson Advisors LLP
- About Us
- Contact Us
- Message Us
- Meet Us
- FAQ's
- Mission and Vision
- Expertise
- Services
- Lower to Mid Market
- Corporate Divestitures
- Healthcare AI
- Digital Health
- Transactions
- Behaviour Change
- App Platform Data AI
- Research
- University Business Schools
- Thought Leadership
- Careers
- Lloyd G Price
- Press and Awards
- Blog
- Insights
- Newsletter
Lloyd Price, Nelson Advisors: Operational Pedigree, Founder Led Advisory and Ecosystem Influence
NA
The healthcare technology (HealthTech), medical technology (MedTech) and healthcare artificial intelligence (AI) sectors across the United Kingdom and Europe are experiencing a profound structural realignment. Departing from the unconstrained capital deployment and inflated valuation multiples of the early 2020s, current enterprise evaluations are governed by clinical utility, regulatory resilience and seamless integration into established care delivery workflows. Within this evolving macroeconomic market, traditional corporate finance pipelines, historically dominated by accounting professionals and generalist investment bankers, face structural limitations when evaluating software-as-a-service (SaaS) metrics alongside complex clinical pathways, interoperability standards, and public health system procurement bottlenecks.
Lloyd Price has established himself as a prominent figure within UK and European digital health investment banking, operating through a specialised "founder-for-founder" advisory model. As a Co-Founder and Partner at Nelson Advisors, Price combines over 25 years of operational leadership across consumer internet platforms and specialised healthcare scaling with lower-to-middle market transaction execution. His operational background, most notably co-founding the digital patient engagement platform Zesty and guiding it through multiple institutional funding rounds to an acquisition by a FTSE-listed entity, provides him with personal experience in hospital system integration, clinical governance and strategic trade sales.
This report presents an analysis of Lloyd Price’s operational trajectory, the advisory methodology of Nelson Advisors, the structural shifts defining European HealthTech M&A, his academic and governance footprint, and his commentary across global media platforms.